Clinical Trial Update: Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating arsenic trioxide for stage IV prostate cancer that progressed after hormone therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Arsenic Trioxide (arsenic trioxide)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED